Treating COVID-19 in Nonhospitalized Patients
A new study sought to address how we approach treatments for these patients.
Related Articles
Pneumonia Diagnostic Shows Limited Utility
The streptococcal pneumoniae urine antigen (SPUA) test was studied over the course of a year to determine if it provided any benefits in terms of…
A Multi-Year Analysis on Antimicrobial Use on Clostridioides difficile Infection
A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference assesses the link between antibiotic use and C difficile infection in Tennessee.
Is There an Association Between Hepatitis C and Prostate Cancer?
An analysis of NHANES data found no significant association between HCV infection and risk of prostate cancer, contrary to findings from previous research.
Nigeria is the First Country to Implement the Men5CV Vaccine Recommended by WHO
Men5CV is expected to target 5 strains of the meningococcus bacteria, reducing meningitis cases across the region.
Study Reveals Transmission of Candida auris from Adults to Children in Maryland Hospital
The results were presented at the Society for Healthcare Epidemiology of America (SHEA) conference, highlighting this first documented case of C auris moving from an…
GSK 5-in-1 Meningococcal Vaccine Given a PDUFA
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Clostridioides Difficile Infection Testing Patterns and Outcomes Following Laxative Administration
A study, presented at the Society for Healthcare Epidemiology of America (SHEA) conference, assesses laxative administration before CDI testing in Veteran Affairs (VA) hospitals and…
AI in HAI Prevention: A Sustainable Approach
Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.
More Than Half of Severe COVID-19 Inpatients Have Persistent Health Issues Post Hospitalization
A small study found physical health problems lingered 1 year after their hospital stay.
GSK 5-in-1 Meningococcal Vaccine Given a PDUFA
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.